About Inherent Biosciences
Inherent Biosciences is a company based in Salt Lake City (United States) founded in 2019 by Kristin Brogaard and Andy Olson.. Inherent Biosciences offers products and services including SpermQT and Epigenetic Platform. Inherent Biosciences operates in a competitive market with competitors including Oxford Biodynamics, ADmit Therapeutics, Age Labs, Chronomics and Oncgnostics, among others.
- Headquarter Salt Lake City, United States
- Founders Kristin Brogaard, Andy Olson
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.03 M (USD), Grant
Feb 05, 2024
-
Investors
NIH
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inherent Biosciences
Inherent Biosciences offers a comprehensive portfolio of products and services, including SpermQT and Epigenetic Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-based test analyzes epigenetic patterns in sperm for personalized infertility treatment.
Detects gene expression dysregulation to diagnose and treat complex diseases like infertility.
Unlock access to complete
Unlock access to complete
Funding Insights of Inherent Biosciences
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $1.0M
-
First Round
First Round
(01 Sep 2020)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Grant - Inherent Biosciences | Valuation |
investors |
|
| May, 2023 | Amount | Grant - Inherent Biosciences | Valuation |
investors |
|
| Sep, 2022 | Amount | Series A - Inherent Biosciences | Valuation | Propel Bio Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inherent Biosciences
Inherent Biosciences has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, National Science Foundation and Propel Bio Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment strategies are developed for life science companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm creating funds for innovative companies in women's health and emerging markets.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inherent Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inherent Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inherent Biosciences Comparisons
Competitors of Inherent Biosciences
Inherent Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Biodynamics, ADmit Therapeutics, Age Labs, Chronomics and Oncgnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Personalized diagnostics are developed via epigenetics for biomarker detection.
|
|
| domain | founded_year | HQ Location |
Early Alzheimer's detection is facilitated through blood-based epigenetic diagnostics.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic solutions are developed for age-related disease detection.
|
|
| domain | founded_year | HQ Location |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
|
| domain | founded_year | HQ Location |
Epigenetic biomarkers for cancer detection and diagnosis are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inherent Biosciences
Frequently Asked Questions about Inherent Biosciences
When was Inherent Biosciences founded?
Inherent Biosciences was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Inherent Biosciences located?
Inherent Biosciences is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Who is the current CEO of Inherent Biosciences?
Andy Olson is the current CEO of Inherent Biosciences. They have also founded this company.
What does Inherent Biosciences do?
Inherent Biosciences was founded in 2019 in Salt Lake City, United States, within the biotechnology sector. Epigenetic diagnostics and therapeutics are developed to address complex diseases. Dysregulation across multiple genes and related pathways is identified using the platform. Diagnosis and treatment of conditions like infertility are targeted. The initial product, SpermQT, is designed for fertility testing and personalized treatment plans.
Who are the top competitors of Inherent Biosciences?
Inherent Biosciences's top competitors include ADmit Therapeutics, Oxford Biodynamics and Age Labs.
What products or services does Inherent Biosciences offer?
Inherent Biosciences offers SpermQT and Epigenetic Platform.
Who are Inherent Biosciences's investors?
Inherent Biosciences has 10 investors. Key investors include NIH, National Science Foundation, Propel Bio Partners, Portfolia, and Alliance of Angels.